Ardelyx, Inc.

Ardelyx, Inc.

Ardelyx, Inc.

Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.
Founded
2007
Raised
$30M
Follow us
Alexa global traffic share
Latest funding
$30,000,000
Venture capital (Series B) - 2011
CMEA Capital NEA Amgen Ventures
Team Size
10+
Employees
MedCity News

FDA turns down Ardelyx’s chronic kidney disease drug and asks for another trial